This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Boschiroli, M. L. Articles by Rossetti, O. L. Search for Related Content PubMed PubMed Citation Articles by Boschiroli, M. L. Articles by Rossetti, O. L.

 Previous Article  |  Next Article 

Infect. Immun., 02 1997, 798-800, Vol 65, No. 2
Copyright © 1997, American Society for Microbiology

Protection against infection in mice vaccinated with a Brucella abortus mutant

ML Boschiroli, SL Cravero, AI Arese, E Campos and OL Rossetti
Instituto de Biotecnologia, Centro de Investigacion en Ciencias Veterinarias, Moron, Provincia Buenos Aires, Argentina.

This study determines whether a genetically engineered mutant of Brucella abortus, strain M-1, possesses differences in protective properties compared to the parental strain, vaccine S19. M-1 is a mutant unable to express BP26, a periplasmic protein with potential use in diagnosis. Mice vaccinated with S19 developed antibodies against BP26, while those vaccinated with M-1 did not. However, mice vaccinated with S19 or M-1 were similarly protected against challenge with pathogenic strain 2308, suggesting that the lack of BP26 does not affect the induction of the protective immune response exerted by S19. These and previous results showing that bacterial invasion and growth or replication in mouse spleens were indistinguishable between strains M-1 and S19 could indicate that the mutant is an attenuated strain which maintains the same protective properties as S19.

This article has been cited by other articles:

• Yang, X., Hudson, M., Walters, N., Bargatze, R. F., Pascual, D. W. (2005). Selection of Protective Epitopes for Brucella melitensis by DNA Vaccination. Infect. Immun. 73: 7297-7303 [Abstract] [Full Text]  
• Izadjoo, M. J., Bhattacharjee, A. K., Paranavitana, C. M., Hadfield, T. L., Hoover, D. L. (2004). Oral Vaccination with Brucella melitensis WR201 Protects Mice against Intranasal Challenge with Virulent Brucella melitensis 16M. Infect. Immun. 72: 4031-4039 [Abstract] [Full Text]  
• Seco-Mediavilla, P., Verger, J.-M., Grayon, M., Cloeckaert, A., Marin, C. M., Zygmunt, M. S., Fernandez-Lago, L., Vizcaino, N. (2003). Epitope Mapping of the Brucella melitensis BP26 Immunogenic Protein: Usefulness for Diagnosis of Sheep Brucellosis. CVI 10: 647-651 [Abstract] [Full Text]  
• Cloeckaert, A., Baucheron, S., Vizcaino, N., Zygmunt, M. S. (2001). Use of Recombinant BP26 Protein in Serological Diagnosis of Brucella melitensis Infection in Sheep. CVI 8: 772-775 [Abstract] [Full Text]  
• Cloeckaert, A., Weynants, V., Godfroid, J., Verger, J.-M., Grayon, M., Zygmunt, M. S. (1998). O-Polysaccharide Epitopic Heterogeneity at the Surface of Brucella spp. Studied by Enzyme-Linked Immunosorbent Assay and Flow Cytometry. CVI 5: 862-870 [Abstract] [Full Text]  
• Tibor, A., Jacques, I., Guilloteau, L., Verger, J.-M., Grayon, M., Wansard, V., Letesson, J.-J. (1998). Effect of P39 Gene Deletion in Live Brucella Vaccine Strains on Residual Virulence and Protective Activity in Mice. Infect. Immun. 66: 5561-5564 [Abstract] [Full Text]